Company Filing History:
Years Active: 2007-2010
Title: The Innovations of Molly Accola
Introduction
Molly Accola is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of genetic testing, particularly in the detection of mutations associated with hearing impairment and cystic fibrosis. With a total of two patents to her name, Accola's work has the potential to impact many lives.
Latest Patents
Molly Accola's latest patents include the Connexin allele detection assays and CFTR allele detection assays. The Connexin allele detection assays provide compositions and methods for detecting and characterizing mutations associated with non-syndromic hearing impairment. This invention utilizes invasive cleavage structure assays, such as the INVADER assay, to screen nucleic acid samples from patients for specific mutations in the Connexin 26 gene. The CFTR allele detection assays focus on mutations associated with cystic fibrosis, offering similar methodologies for screening CFTR gene mutations in patients.
Career Highlights
Accola is currently employed at Third Wave Technologies, Inc., where she continues to innovate in the field of genetic testing. Her work has garnered attention for its practical applications in diagnosing genetic disorders, which can lead to better patient outcomes.
Collaborations
Molly Accola has collaborated with notable coworkers, including Susan S Wigdal and Andrea L Mast. These partnerships have likely contributed to the success of her inventions and the advancement of genetic testing technologies.
Conclusion
Molly Accola's contributions to genetic testing through her innovative patents demonstrate her commitment to improving healthcare. Her work in detecting genetic mutations is paving the way for advancements in medical diagnostics.